Barone Francesca 4
4 · Candel Therapeutics, Inc. · Filed Feb 7, 2022
Insider Transaction Report
Form 4
Barone Francesca
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-03+40,000→ 40,000 totalExercise: $4.06Exp: 2032-02-03→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments over four years following the Grant Date, subject to the Reporting Person's continued service on each such vesting date.